Two ground-breaking studies have demonstrated that combining artificial intelligence (AI) with state-of-the-art MRI imaging could revolutionise how clinicians detect, monitor and treat advanced ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Tony McHale (pictured above) discovered he had an alteration in the BRCA2 gene at the age of 61, putting him at a much higher risk of developing prostate cancer. Shortly after, Tony joined the IMPACT ...

We applied the principle of synthetic lethality to discover a novel strategy for cancer treatment for patients with BRCA1 or BRCA2 gene mutations. We demonstrated that drugs called PARP inhibitors ...

Evolutionary biology isn’t a sub-topic of cancer sciences - it is a conceptual framework for everything in cancer. In recognition of this important development and the research opportunities it ...

We identified the breast cancer gene BRCA2, which enabled families with a history of breast cancer to be assessed for future risk, and laid the groundwork for developing novel forms of therapy for ...

Our leadership teamProfessor Kristian Helin Chief Executive and President The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and ...

Radiotherapy and imaging training courses The Division of Radiotherapy and Imaging offers a number of related courses to internal and external audiences. Course dates and places are limited - contact ...

The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Oakleaf Avenue, Sutton, Surrey, UK. This course is organised by the Joint Department of Physics of The Royal Marsden NHS ...

Advocacy engagement: policy and public affairs Our policy priorities Creating a sustainable funding model for research in universities Encouraging international talent to support cancer research ...

Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Cancer patients are living longer and with a better quality ...

The Institute of Cancer Research, London, works closely with a number of funding organisations, including Cancer Research UK, Breast Cancer Now and the Wellcome Trust. We also have a close partnership ...